Liposome encapsulation attenuates hemoglobin-induced vasoconstriction in rabbit arterial segments

Journal of Applied Physiology

Volumn 82, Issue 6, 1997, Pages 1826-1835

  Rudolph, Alan S ^a   Sulpizio, Anthony ^b   Hieble, Paul ^b   Macdonald, Victor ^c   Chavez, Mark ^c   Feuerstein, Giora ^b  

^a NAVAL RESEARCH LABORATORY   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Blood substitute; Nitric oxide

Indexed keywords

HEMOGLOBIN; LIPOSOME; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE SYNTHASE; NORADRENALIN;

ANIMAL TISSUE; ARTICLE; CROSS LINKING; EAR ARTERY; ELECTROSTIMULATION; ENCAPSULATION; ENZYME ACTIVITY; LUNG ARTERY; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RABBIT; THORACIC AORTA; VASOCONSTRICTION; VASODILATATION;

EID: 0030949333     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1997.82.6.1826     Document Type: Article

References (56)

1. 3H-noradrenaline release in rabbit ear artery. Pharmacology 42: 79-85, 1991.
2. Amberson, W. R., J. Flexner, F. R. Steggerda, A. G. Mulder, M. J. Tendler, D. S. Pandratz, and E. P. Lan. On the use of Ringer-Locke solutions containing hemoglobin as a substitute for normal blood in mammals. J. Cell. Comp. Physiol. 5: 359-382, 1934.
3. Amberson, W. R., J. J. Jennings, and C. M. Rhode. Clinical experience with hemoglobin-saline solutions. J. Appl. Physiol. 1: 156-169, 1949.
4. Anand, N., and W. G. Paterson. Role of nitric oxide in esophageal peristalsis. Am. J. Physiol. 266 (Gastrointest. Liver Physiol. 29): G123-G131, 1994.
5. Balla, J., K. A. Nath, G. Balla, M. B. Juckett, H. S. Jacob, and G. M. Vercellotti. Endothelial cell heme oxygenase and ferritin induction in rat lungs by hemoglobin in vivo. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L321-L327, 1995.
6. Bredt, D. S., and S. H. Snyder. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. USA 86: 9030-9033, 1989.
7. Chang, T. M. S. Semi-permeable microcapsules. Science 146: 524-525, 1964.
8. Collins, P., J. Burman, H. I. Chung, and K. Fox. Hemoglobin inhibits endothelium, dependent relaxation to acetylcholine in human coronary arteries in vivo. Circulation 87: 80-85, 1993.
9. Connor, H. E., and W. Feniul. Role of endothelium in hemoglobin induced contraction of dog basilar artery. Eur. J. Pharmacol. 140: 105-108, 1987.
10. Djordjevich, L., and I. F. Miller. Synthetic erythrocytes from lipid-encapsulated hemoglobin. Exp. Hematol. 8: 584-592, 1980.
11. Dodd, R. Y. The risk of transfusion-transmitted infection. N. Engl. J. Med. 327: 419-421, 1992.
12. Farmer, M. C., A. S. Rudolph, K. D. Vandegriff, M. D. Hayre, S. A. Bayne, and S. A. Johnson. Liposome-encapsulated hemoglobin: oxygen binding properties and respiratory function. Biomat. Artif. Cells Artif. Organs 16: 289-299, 1988.
13. Feola, M., J. Simoni, P. C. Canizaro, R. Tran, and G. Raschbaum. Mechanisms of toxicity of hemoglobin solutions. Surg. Gynecol. Obstet. 166: 211, 1988.
14. Furchgott, R. F., and J. V. Zawadzki. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
15. Gilroy, D., C. Shaw, E. Parry, and W. Odling-Smee. Detection of a vasoconstrictor factor in stroma-free hemoglobin solutions. J. Trauma 28: 1312-1316, 1989.
16. Goins, B., R. Klipper, J. Sanders, R. O. Cliff, A. S. Rudolph, and W. T. Phillips. Physiological responses, organ distribution, and circulation kinetics in anesthetized rats after hypovolemic exchange transfusion with technetium-99m-labeled liposome-encapsulated hemoglobin. Shock 4: 121-130, 1995.
17. Gulati, A., and S. Rebello. Role of adrenergic mechanisms in the pressor effect of diaspirin cross-linked hemoglobin. J. Lab. Clin. Med. 124: 125-133, 1994.
18. Hess, J. R., V. W. MacDonald, and W. W. Brinkley. Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J. Appl. Physiol. 74: 1769-1778, 1993.
19. Hille, R., G. Palmer, and J. S. Olson. Chain equivalence in reaction of nitric oxide with hemoglobin. J. Biol. Chem. 252: 403-405, 1977.
20. Hunt, C. A., R. R. Burnette, R. D. MacGregor, A. Strubbe, D. T. Lau, N. Taylor, and H. Kawada. Synthesis and evaluation of a prototypal artificial red cell. Science 230: 1165-1168, 1985.
21. Keipert, P. E., and L. Triner. Catabolism and excretion of cross-linked hemoglobin. In: The Red Cell: 7th Ann Arbor Conf. New York: Liss, 1989, p. 383-405.
22. Kobayashi, Y., K. Ikebuchi, and S. Sekiguchi. Comparison of endothelial cell permeability of acellular and cellular hemoglobin. Artif. Cells Blood Sub. Immobil. Biotech. 24: 364, 1996.
23. Lasic, D. D., and D. Papahadjopoulos. Liposomes revisited. Science 267: 1275-1276, 1995.
24. MacDonald, V. W., and R. Motterlini. Cell-free hemoglobin potentiates acetylcholine-induced coronary vasoconstriction in rabbit hearts. J. Appl. Physiol. 75: 2224-2233, 1993.
25. Martin, W., J. A. Smith, and D. G. White. The mechanism by which hemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilators, nitric oxide, or bovine retractor penis inhibitory factor. Br. J. Pharmacol. 89: 563-571, 1986.
26. Martin, W., G. M. Villani, J. Designaro, and F. Furchgott. Selective blockade of endothelium-dependent glycerol trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J. Pharmacol. Exp. Ther. 232: 708-716, 1985.
27. Marwick, C. More than a trickle of interest in blood substitutes. J. Am. Med. Assoc. 271: 895, 1994.
28. Matheson, I. B. C. The method of successful integration: a general technique for recasting kinetic equations in a readily soluble form which is linear in the coefficients and sufficiently rapid for real time instrumental use. Anal. Instrum. 16: 345-373, 1987.
29. Morris, R. J., and Q. H. Gibson. The role of diffusion in limiting the rate of ligand binding to hemoglobin. J. Biol. Chem. 255: 8050-8053, 1980.
30. Moss, G. S., R. DeWoskin, A. L. Rosen, H. Levine, and C. K. Palani. Transport of oxygen and carbon dioxide by hemoglobin-saline solution in the red cell free primate. Surg. Gynecol. Obstet. 142: 357-362, 1976.
31. Moss, G. S., S. A. Gould, A. L. Rosen, L. R. Sehgal, and H. L. Sehgal. Results of the first clinical trial with a polymerized hemoglobin solution (Abstract). Biomat. Artif. Cells Artif. Organs 17: 633, 1989.
32. Muldoon, S., J. Hart, and M. Ledvina. DCLHb-induced contractions of isolated blood vessels are dependent on nitric oxide production. Artif. Cells Blood Sub. Immobil. Biotech. 24: 392-398, 1996.
33. Murray, J. A., A. Ledlow, J. Launspach, D. Evans, M. Loveday, and J. L. Conklind. The effects of recombinant human hemoglobin on esophageal motor function in humans. Gastroenterology 109: 1241-1248, 1995.
34. Ning, J., L. M. Peterson, P. J. Anderson, and G. P. Biro. Systemic hemodynamic and renal effects of unmodified human SFHS in dogs. Artif. Cells Immob. Biotech. 20: 723-727, 1992.
35. Olson, J. S. Stopped-flow, rapid mixing measurements of ligand binding to hemoglobin and red cells. In: Methods in Enzymology, edited by E. Antonini, L. Rossi-Bernardi, and E. Chiancone. New York: Academic, 1981, vol. 76, p. 631-651.
36. Przybelski, J., D. S. Malcolm, D. G. Burris, and R. M. Winslow. Cross-linked hemoglobin as a resuscitative fluid after hemorrhage in the rat. J. Lab. Clin. Med. 117: 143-151, 1991.
37. Rabinovici, R., A. S. Rudolph, and G. Feuerstein. Characterization of hemodynamic, hematological, and biochemical responses to administration of liposome-encapsulated hemoglobin in the conscious, freely moving rat. Circ. Shock 29: 115-132, 1989.
38. Rabinovici, R., A. S. Rudolph, and G. Feuerstein. Improved biological properties of synthetic distearoyl phosphatidyl choline-based liposome in the conscious rat. Circ. Shock 30: 207-219, 1990.
39. Rabinovici, R., A. S. Rudolph, F. S. Ligler, E. F. Smith, and G. Feuerstein. Biological responses to exchange transfusion with liposome encapsulated hemoglobin. Circ. Shock 37: 124-133, 1992.
40. Rabinovici, R., A. S. Rudolph, J. Vernick, and G. Feuerstein. A new salutary resuscitative fluid: liposome encapsulated hemoglobin/hypertonic saline solution. J. Trauma 35: 121-127, 1993.
41. Rabinovici, R., A. S. Rudolph, T. L. Yue, and G. Feuerstein. Biological responses to liposome-encapsulated hemoglobin (LEH) are improved by a PAF antagonist. Circ. Shock 31: 431-445, 1990.
42. Rioux, F., E. Petitclerc, R. Audet, G. Drapeau, R. M. Fielding, and F. Marceau. Recombinant human hemoglobin inhibits both constitutive and cytokine-induced nitric oxide-mediated relaxation of rabbit isolated aortic rings. J. Cardiovasc. Pharmacol. 24: 229-237, 1994.
43. Rudolph, A. S. The freeze-dried preservation of liposome encapsulated hemoglobin: a potential blood substitute. Cryobiology 25: 277-284, 1988.
44. 99mTc-labeled liposome encapsulated hemoglobin in an anesthetized rabbit. Proc. Natl. Acad. Sci. USA 88: 10976-10980, 1991.
45. Savitsky, J. P., J. Doczi, J. Black, and J. D. Arnold. A clinical safety trial of stroma-free hemoglobin. Clin. Pharmacol. Ther. 23: 73-80, 1978.
46. Schultz, S. C., B. Grady, F. Cole, I. Hamilton, K. Burhop, and D. Malcolm. A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J. Lab. Clin. Med. 122: 301-308, 1993.
47. Sharma, A. C., and A. Gulati. Effect of diaspirin cross-linked hemoglobin and norepinephrine on systemic hemodynamics and regional circulation in rats. J. Lab. Clin. Med. 123: 299-308, 1994.
48. Sharma, A., and A. Gulati. Yohimbine modulates diaspirin cross-linked hemoglobin-induced systemic hemodynamics and regional circulatory effects. Crit. Care Med. 23: 1-11, 1995.
49. Steinsland, O. S., R. F. Furchgott, and R. Kirpekar. Biphasic vasoconstriction of rabbit ear artery. Circ. Res. 32: 49-58, 1973.
50. Thompson, A., A. E. McGarry, V. Valeru, and L. Leiberthal. Stroma-free hemoglobin increases blood pressure and GFR in the hypotensive rat: role of nitric oxide. J. Appl. Physiol. 77: 2348-2354, 1994.
51. Toda, N. Mechanisms of contracting action of oxyhemoglobin in isolated monkey and dog cerebral arteries. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H57-H63, 1990.
52. Tsai, A., H. Kerger, and M. Intaglietta. Microcirculatory consequences of blood substitutes with hemoglobin. In: Blood Substitutes: Physiological Basis of Efficacy. Boston, MA: Birkhauser, 1995, p. 155-175.
53. Winslow, R. M. The toxicity of hemoglobin. In: The Hemoglobin Based Red Cell Substitutes. Baltimore, MD: Johns Hopkins Univ. Press, 1992, p. 136-162.
54. Winslow, R. M., and K. W. Chapman. Pilot scale preparation of hemoglobin solutions. In: Methods of Enzymology: Hemoglobins B, Biochemical and Analytical Methods. San Diego, CA: Academic, 1994, vol. 231, p. 3-16.
55. Wright, I. K., N. A. Blaylock, D. A. Kendall, and V. G. Wilson. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels. Br. J. Pharmacol. 114: 678-688, 1995.
56. Zuck, T. F., and J. G. Riess. Current status of injectable oxygen carriers. Crit. Rev. Clin. Lab. Sci. 31: 295-324, 1994.